To investigate whether it was required for Kras overexpression and p53 function lose-driven lung cancer cell growth, we knocked down HK2 in KP2 cells and H23 cells with three independent shRNAs: shHK2-01, shHK2-02 and shHK2-03. The gene discussed is TP53; the disease is lung carcinoma.